GlaxoSmithKline PLC News Headlines

GSK 
$48.67
*  
0.41
0.85%
Get GSK Alerts
*Delayed - data as of Aug. 27, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    GSK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Stocks Mixed Ahead of Fed Chatter, Debt Ceiling Debate
9/20/2013 9:09:11 AM - MT Newswires

Sector Update: Healthcare Shares Mixed Pre-Market; Sarepta Sinks 10% on GlaxoSmithKline, Prosensa Study
9/20/2013 8:22:09 AM - MT Newswires

Sector Update: Healthcare
9/20/2013 8:17:31 AM - MT Newswires

ChemoCentryx Regains Rights to Vercirnon - Analyst Blog
9/19/2013 4:20:01 PM - Zacks.com

Good News Flows in at Glaxo - Analyst Blog
9/19/2013 12:10:01 PM - Zacks.com

IPO Preview: Five Prime Therapeutics
9/17/2013 4:34:00 PM - Seeking Alpha

DiaDexus Awaiting GSK's Darapladib Pivotal Results
9/17/2013 1:36:00 PM - Seeking Alpha

Verdict on Glaxo's Lovaza - Analyst Blog
9/17/2013 10:58:45 AM - Zacks.com

Glaxo Reports Positive Data - Analyst Blog
9/16/2013 12:58:06 PM - Zacks.com

Epizyme: The Promise Of Personalized Cancer Therapy
9/15/2013 8:21:00 PM - Seeking Alpha

Good News for Perrigo - Analyst Blog
9/13/2013 10:57:49 AM - Zacks.com

Amarin's Problems Just Went From Bad To Worse
9/13/2013 12:32:00 AM - Seeking Alpha

Update on XenoPort's Horizant - Analyst Blog
9/12/2013 5:45:01 PM - Zacks.com

FDA Panel Backs THRX/GSK Candidate - Analyst Blog
9/11/2013 6:58:03 PM - Zacks.com

Neurocrine And ChemoCentryx: Phase II Data Disappoints
9/11/2013 10:48:00 AM - Seeking Alpha

Glaxo to Divest Lucozade and Ribena - Analyst Blog
9/10/2013 3:57:58 PM - Zacks.com

Tivicay: A Blockbuster Opportunity For GlaxoSmithKline And Pfizer?
9/10/2013 3:01:00 PM - Seeking Alpha

Today's Market: Market Moving News For Big Pharma, Biotech & Airlines
9/9/2013 9:26:00 AM - Seeking Alpha

DiaDexus: A Hearty Choice
9/8/2013 8:35:00 PM - Seeking Alpha

Agenus Offers An Investment Opportunity
9/8/2013 4:51:00 AM - Seeking Alpha

Healthcare Stocks Rising; GSK Said Close to Selling Ribena, Lucozade Brands to Japanese Drinks Giant
9/6/2013 2:34:48 PM - MT Newswires

Sector Update: Healthcare
9/6/2013 2:30:15 PM - MT Newswires

Setback for Glaxo's Cancer Pipeline - Analyst Blog
9/6/2013 11:51:52 AM - Zacks.com

Digging Below The Surface Of Neurotechnology: Casey Lynch
9/6/2013 11:10:00 AM - Seeking Alpha

Healthcare Sector Slightly Higher Near Bell; Neuralstem Gains After Pricing $4-Mln Private Offering
9/5/2013 3:41:00 PM - MT Newswires